Description
CCK-Octapeptide (26-33) (Sulfated Form)
| Catalog number: | MDP0472 |
| CAS Number: | N/A |
| Sequence: | Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2 |
| Amount: | 500 ug |
| Molecular Weight: | 1143.2 g/mol |
| Supplied as: | Powder |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20 C |
| WARNING: | For in vitro Research Use Only. NOT for use on humans or animals. |
| Grade: | Biotechnology grade. All products are highly pure. |
References
- Janah L, Kjeldsen S, Galsgaard KD, Winther-Srensen M, Stojanovska E, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ. Glucagon Receptor Signaling and Glucagon Resistance Int J Mol Sci. 2019 Jul 5;20(13):3314.
- Zeigerer A, Sekar R, Kleinert M, Nason S, Habegger KM, Mller TD. Glucagons Metabolic Action in Health and Disease Compr Physiol. 2021 Apr 1;11(2):1759-1783.
- Kleinert M, Sachs S, Habegger KM, Hofmann SM, Mller TD. Glucagon Regulation of Energy Expenditure Int J Mol Sci. 2019 Oct 30;20(21):5407.
- Kulina GR, Rayfield EJ. THE ROLE OF GLUCAGON IN THE PATHOPHYSIOLOGY AND MANAGEMENT OF DIABETES Endocr Pract. 2016 May;22(5):612-21.
- Lund A, Knop FK. Extrapancreatic glucagon: Present status Diabetes Res Clin Pract. 2019 Jan;147:19-28.
- Eaton RP. Evolving role of glucagon in human diabetes mellitus Diabetes. 1975 May;24(5):523-4.
- Byrne MM, Gke B. Human studies with glucagon-like-peptide-1: potential of the gut hormone for clinical use Diabet Med. 1996 Oct;13(10):854-60.
- Downes MA. Glucagon Emerg Med (Fremantle). 2003 Oct-Dec;15(5-6):480-5.
- Marks V. Glucagon Clin Endocrinol Metab. 1972 Nov;1(3):829-45.
